Velthuis 2010.

Study name	PACT
Methods	RCT
Participants	Participants with breast or colon cancer undergoing cancer treatment
Interventions	An 18‐week supervised group or control group asked to maintain their habitual physical activity pattern
Outcomes	Primary outcome is fatigue assessed using the MFI and the FQL. Secondary outcomes include HRQoL assessed using the EORTC QLQ‐C30 (Version 3) and the SF‐36, perceived impact of the disease on participation and autonomy assessed using the IPA questionnaire, anxiety and depression assessed using the Dutch language version of the HADS, physical fitness, BMI, body fat distribution, self efficacy about the performance of physical activity, and physical activity level
Starting date	Not reported
Contact information	Miranda J Velthuis, Comprehensive Cancer Center Middle Netherlands, Utrecht, the Netherlands
Notes	Published protocol. Trial registration: Current Controlled trials ISRCTN43801571, Dutch Trial Register NTR2138

ADT: androgen deprivation therapy; BMD: bone mineral density; BMI: body mass index; BSI‐18: Brief Symptom Inventory‐18; DXA: dual energy X‐ray absorptiometry; DCIS: ductal carcinoma in situ; EORTC: European Organization for Research and Treatment of Cancer: FACT‐P: Functional Assessment of Cancer Therapy ‐ prostate; Functional Assessment of Cancer Therapy ‐ Prostate; FQL: Fatigue Quality List; FSS: Fatigue Severity Scale; GED: general educational development; HADS: Hospital Anxiety and Depression Scale; HIPRT: high‐intensity progressive resistance training; HRQoL: health‐related quality of life; IPA: Impact on Participation and Autonomy; MFI: Multidimensional Fatigue Inventory; PSQI: Pittsburgh Sleep Quality Index; PSS‐10: Perceived Stress Scale; EORTC QLQ‐C30: European Organization for Research and Treatment of Cancer: Quality of Life Questionnaire‐C30; QoL: quality of life; RCT: randomized controlled Trial; SF‐36: Short Form‐36.